A Multicenter, Human Factors Validation Study in Cystic Fibrosis Patients Aged 6 Years and Older to Evaluate the User Interface of TOBI Podhaler(Tobramycin Inhalation Powder) Using Placebo Capsules
Phase of Trial: Phase IV
Latest Information Update: 29 Apr 2019
Price : $35 *
At a glance
- Drugs Tobramycin (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors Mylan; Novartis Pharmaceuticals
- 25 Apr 2019 Status changed from recruiting to completed.
- 11 Jul 2018 Status changed from not yet recruiting to recruiting.
- 20 Apr 2018 New trial record